Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice

Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice

Abstract Patients with chronic kidney disease (CKD) have elevated circulating levels of trimethylamine N-oxide (TMAO), a metabolite derived from gut microbes and associated with cardiovascular diseases. High circulating levels of TMAO and its dietary precursor, choline, predict increased risk for de...

Full description

Bibliographic Details
Main Authors:	Wenchao Zhang, Aika Miikeda, Jonathan Zuckerman, Xun Jia, Sarada Charugundla, Zhiqiang Zhou, Karolina Elżbieta Kaczor-Urbanowicz, Clara Magyar, Fangfei Guo, Zeneng Wang, Matteo Pellegrini, Stanley L. Hazen, Susanne B. Nicholas, Aldons J. Lusis, Diana M. Shih
Format:	Article
Language:	English
Published:	Nature Publishing Group 2021-01-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-020-80063-0

Similar Items

Simultaneous Measurement of Urinary Trimethylamine (TMA) and Trimethylamine <i>N</i>-Oxide (TMAO) by Liquid Chromatography–Mass Spectrometry
by: Xun Jia, et al.
Published: (2020-04-01)

NOTUM promotes thermogenic capacity and protects against diet-induced obesity in male mice
by: Fangfei Guo, et al.
Published: (2021-08-01)

The TMAO-Generating Enzyme Flavin Monooxygenase 3 Is a Central Regulator of Cholesterol Balance
by: Manya Warrier, et al.
Published: (2015-01-01)

Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota
by: Ming-liang Chen, et al.
Published: (2016-04-01)

Effect of urea and tmao on lipid bilayers
by: Valerio J., et al.
Published: (2017-11-01)

Mechanisms mediating insulin resistance in transgenic mice overexpressing mouse apolipoprotein A-II
by: Lawrence W. Castellani, et al.
Published: (2004-12-01)

The TMAO-Producing Enzyme Flavin-Containing Monooxygenase 3 Regulates Obesity and the Beiging of White Adipose Tissue
by: Rebecca C. Schugar, et al.
Published: (2017-06-01)

The TMAO-Producing Enzyme Flavin-Containing Monooxygenase 3 Regulates Obesity and the Beiging of White Adipose Tissue
by: Rebecca C. Schugar, et al.
Published: (2017-07-01)

Gut Microbiota Dysbiosis and Increased Plasma LPS and TMAO Levels in Patients With Preeclampsia
by: Jing Wang, et al.
Published: (2019-12-01)

TMAO: a potential mediator of clopidogrel resistance
by: Ruisong Ma, et al.
Published: (2021-03-01)

Dietary allicin reduces transformation of L-carnitine to TMAO through impact on gut microbiota
by: Wei-Kai Wu, et al.
Published: (2015-05-01)

Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis[S]
by: Diana M. Shih, et al.
Published: (2015-01-01)

Background Diet Influences TMAO Concentrations Associated with Red Meat Intake without Influencing Apparent Hepatic TMAO-Related Activity in a Porcine Model
by: Rebekka Thøgersen, et al.
Published: (2020-02-01)

Marked elevation in plasma trimethylamine-N-oxide (TMAO) in patients with mitochondrial disorders treated with oral l-carnitine
by: H.D. Vallance, et al.
Published: (2018-06-01)

Mechanism of Prominent Trimethylamine Oxide (TMAO) Accumulation in Hemodialysis Patients.
by: Xin Hai, et al.
Published: (2015-01-01)

DNA Methylation Changes More Slowly Than Physiological States in Response to Weight Loss in Genetically Diverse Mouse Strains
by: Chantle R. Edillor, et al.
Published: (2019-12-01)

Gut microbiota derived trimethylamine N-oxide (TMAO) detection through molecularly imprinted polymer based sensor
by: G. B. V. S. Lakshmi, et al.
Published: (2021-01-01)

Gut-microbiota derived TMAO: A risk factor, a mediator or a bystander in the pathogenesis of atrial fibrillation?
by: Monika Gawałko, et al.
Published: (2021-06-01)

TMA, A Forgotten Uremic Toxin, but Not TMAO, Is Involved in Cardiovascular Pathology
by: Kinga Jaworska, et al.
Published: (2019-08-01)

Association of Urinary and Plasma Levels of Trimethylamine N-Oxide (TMAO) with Foods
by: Mauro Lombardo, et al.
Published: (2021-04-01)

Association of the Chronotype Score with Circulating Trimethylamine N-Oxide (TMAO) Concentrations
by: Luigi Barrea, et al.
Published: (2021-05-01)

Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort
by: Elin Org, et al.
Published: (2017-04-01)

Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection
by: Judith M. Haissman, et al.
Published: (2017-06-01)

Drug Discovery and Development of Novel Therapeutics for Inhibiting TMAO in Models of Atherosclerosis and Diabetes
by: Ian Steinke, et al.
Published: (2020-10-01)

High Mobility Group Box 1 Mediates TMAO-Induced Endothelial Dysfunction
by: Gurinder Bir Singh, et al.
Published: (2019-07-01)

Trimethylamine-N-oxide (TMAO)-induced atherosclerosis is associated with bile acid metabolism
by: Lin Ding, et al.
Published: (2018-12-01)

Trimethylamine N-Oxide (TMAO) and Trimethylamine (TMA) Determinations of Two Hadal Amphipods
by: Jiang, S., et al.
Published: (2022)

Gut Microbiota-Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target
by: Shengjie Yang, et al.
Published: (2019-11-01)

A thematic review series: systems biology approaches to metabolic and cardiovascular disorders
by: Aldons J. Lusis
Published: (2006-09-01)

Gut Metabolite TMAO Induces Synaptic Plasticity Deficits by Promoting Endoplasmic Reticulum Stress
by: Manoj Govindarajulu, et al.
Published: (2020-08-01)

Trimethylamine-N-oxide (TMAO) as Novel Potential Biomarker of Early Predictors of Metabolic Syndrome
by: Luigi Barrea, et al.
Published: (2018-12-01)

Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target
by: Manuel H. Janeiro, et al.
Published: (2018-10-01)

Neighborhood Environment Associates with Trimethylamine-N-oxide (TMAO) As a Cardiovascular Risk Marker
by: Nicole Farmer, et al.
Published: (2021-04-01)

Association of Trimethylamine N-Oxide (TMAO) with the Clinical Severity of Hidradenitis Suppurativa (Acne Inversa)
by: Luigi Barrea, et al.
Published: (2021-06-01)

TMAO, a seafood-derived molecule, produces diuresis and reduces mortality in heart failure rats
by: Marta Gawrys-Kopczynska, et al.
Published: (2020-06-01)

Characterization of TMAO productivity from carnitine challenge facilitates personalized nutrition and microbiome signatures discovery
by: Wei-Kai Wu, et al.
Published: (2020-11-01)

Ginger attenuates trimethylamine-N-oxide (TMAO)-exacerbated disturbance in cholesterol metabolism and vascular inflammation
by: Zouyan He, et al.
Published: (2019-01-01)

Metformin alleviates choline diet-induced TMAO elevation in C57BL/6J mice by influencing gut-microbiota composition and functionality
by: Chunyan Su, et al.
Published: (2021-07-01)

Urinary TMAO Levels Are Associated with the Taxonomic Composition of the Gut Microbiota and with the Choline TMA-Lyase Gene (<i>cutC</i>) Harbored by Enterobacteriaceae
by: Alessandro Dalla Via, et al.
Published: (2019-12-01)

Trimethylamine-N-Oxide (TMAO)-Induced Impairment of Cardiomyocyte Function and the Protective Role of Urolithin B-Glucuronide
by: Monia Savi, et al.
Published: (2018-03-01)